Email
Supergut harnesses the science of the gut microbiome to improve metabolic health through food. When I joined in September 2022 as the company’s first dedicated marketing leader, the brand was a well-kept secret — selling exclusively direct-to-consumer, with a strong scientific foundation but limited market reach and an unclear positioning in a crowded wellness space.
Over the next two and a half years, I rebuilt marketing from the ground up — hiring across growth, brand, creative, social, and influencer — and led the strategic pivot that defined the brand’s breakout: repositioning Supergut squarely in the emerging GLP-1 conversation just as that category exploded into the mainstream.
Coming in as the company’s first overall marketing head, the brief was simple: build. I developed brand strategy, hired the team, stood up an in-house content studio, and overhauled every customer-facing channel — from organic social to email to the product detail pages people land on from paid media. I also led the expansion from a pure DTC model into omnichannel retail, landing distribution at Amazon, Target, GNC, Sprouts, and Erewhon.
The most consequential move was timing. As GLP-1 medications captured public attention and millions of Americans began exploring weight management, I saw an opportunity to reposition Supergut not as a niche gut health brand but as the smart, natural complement to the GLP-1 lifestyle. We rewrote the messaging, rebuilt the creative, and realigned our media strategy around that insight.
The result: annual revenue tripled to $25M while customer acquisition costs dropped 70%. That growth trajectory unlocked a $14M Series B in 2024 — and validated the bet.